[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354004-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354004-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","creb5-regulates-stem-cell-like-transcriptional-programs-to-enhance-tumor-progression-in-prostate-cancer","CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer","","CREB5 is identified as a key regulator linking basal-like and stem cell-like (SCL) transcriptional programs to prostate cancer progression. The study analyzes prostate cancer transcriptomes using in silico modeling and predefined signaling programs, showing CREB5 expression best matches basal-like gene signatures and SCL-associated genes in primary and castration-resistant prostate cancers. Mechanistic evidence demonstrates CREB5 interacts with AP-1 proteins and binds AP-1 regulatory elements. In AR-positive cells, CREB5 overexpression increases colony growth and tumor size in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/creb5-regulates-stem-cell-like-transcriptional-programs-to-enhance-tumor-progression-in-prostate-cancer/354004/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/creb5-regulates-stem-cell-like-transcriptional-programs-to-enhance-tumor-progression-in-prostate-cancer/354004.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does CREB5 play in prostate cancer progression?","Question",{"text":63,"@type":64},"CREB5 regulates basal-like and stem cell-like transcriptional programs and tumor-forming phenotypes in prostate cancer, including castration-resistant settings.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was CREB5 association with basal-like and SCL programs determined?",{"text":68,"@type":64},"Using in silico modeling of prostate cancer transcriptomes and predefined signaling programs, CREB5 expression showed strongest association with basal-like gene signatures and SCL-associated genes.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanistic findings connect CREB5 to AP-1 gene regulation?",{"text":72,"@type":64},"CREB5 was found to interact with AP-1 proteins and bind regulatory elements of AP-1 genes, supporting a direct role in regulating AP-1 activity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354004,1790782169,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www.oncotarget.com](www.oncotarget.com) Oncotarget, 2026, Vol. 17, pp: 59-73  \nResearch Paper  \nCREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer  \nAllison Makovec1,2,3, John T. Phoenix4, Hannah E. Bergom1,2, Ella Boytim1,2, Ava P. Gustafson1,2, Aiden Deacon5, Sydney Tape6, Atef Ali7, Megan Ludwig2,8, Samuel  \nP. Pitzen2,9, David Moline1,2, Camden Richter10, Hudson Longie1,2, Mei-Chi Su11, Sampreeti Jena11, Pornlada Likasitwatanakul1,12, Justin M. Drake2,8, R. Stephanie Huang2,11, William C. Hahn13,14, Jonathan P. Rennhack4, Scott M. Dehm2,15,16, Steven  \nKregel4, Emmanuel S. Antonarakis1,2 and Justin Hwang1,2 1 Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA 2 Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA 3University of Kansas Medical Center, Kansas City, KS 66160, USA  \n4 Department of Cancer Biology, Loyola University Chicago, Chicago, IL 60153, USA 5Cancer Biology Graduate Program, University of Colorado Anschutz, Aurora, CO 80045, USA 6 Medical College of Wisconsin, Green Bay, WI 54115, USA  \n7 Bioinformatic Interdepartmental Program, University of California, Los Angeles, CA 90095, USA 8 Department of Pharmacology, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA  \n9Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN 55455, USA  \n10 Rush University Medical College, Chicago, IL 60612, USA  \n11 Department of Experimental and Clinical Pharmacology, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA 12 Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand  \n13 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA  \n14 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA 15 Department of Laboratory Medicine and Pathology, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA 16 Department of Urology, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA  \nCorrespondence to: Emmanuel S. Antonarakis, [email](email: anton401@umn.edu)[: anton401@umn.edu](email: anton401@umn.edu)  \nJustin Hwang, email: [jhwang@umn.edu](jhwang@umn.edu)[ ](jhwang@umn.edu)Keywords: prostate cancer; CREB5; basal-like; stem cell-like; AP-1 transcription factors  \nReceived: July 21, 2025 Accepted: February 16, 2026 Published: March 17, 2026  \nCopyright: © 2026 Makovec et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4 .0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nProstate gland cells can be transcriptionally and morphologically characterized as basal and luminal. About 30–40% of advanced prostate cancers (PC) harbor basal-like transcription programs. In castration-resistant PC (CRPC), studies indicate that basal and stem cell-like (SCL) tumors are major resistance mechanisms to androgen receptor (AR)-targeted therapies. SCL tumors have reduced AR activity and increased stem-cell activity that promotes tumor formation, which contributes to poor clinical outcomes. We determined that CREB5 is a key regulator of basal and SCL transcriptional programs and tumor-forming phenotypes in PC. Through in silico modeling of PC transcriptomes and several pre-defined PC signaling programs, CREB5 expression was best associated with basal-like gene signatures and SCL-associated genes in primary PC and CRPCs (n = 493 and 208) . This included associations with FOSL1 and other AP-1 transcription factors. We further found that CREB5 interacted  \nwith AP-1 proteins and bound to the regulatory elements of AP-1 genes, suggesting a mechanistic role in regulating the activity of AP-1 genes. In AR-positive cells, CREB5 overexpression promoted cell colony growth with ","cbCaidkygEApl5uu","https://ap.wps.com/l/cbCaidkygEApl5uu","pdf",6223976,15,"English","# Abstract\n# Introduction\n## Androgen receptor signaling and therapy resistance\n## AR-independent disease biology\n## Basal-like and stem cell-like transcriptional programs","[{\"question\":\"What role does CREB5 play in prostate cancer progression?\",\"answer\":\"CREB5 regulates basal-like and stem cell-like transcriptional programs and tumor-forming phenotypes in prostate cancer, including castration-resistant settings.\"},{\"question\":\"How was CREB5 association with basal-like and SCL programs determined?\",\"answer\":\"Using in silico modeling of prostate cancer transcriptomes and predefined signaling programs, CREB5 expression showed strongest association with basal-like gene signatures and SCL-associated genes.\"},{\"question\":\"What mechanistic findings connect CREB5 to AP-1 gene regulation?\",\"answer\":\"CREB5 was found to interact with AP-1 proteins and bind regulatory elements of AP-1 genes, supporting a direct role in regulating AP-1 activity.\"}]","CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer | PDF",1790108432,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0c47a4189d30acf29f276334b8e111e.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c862a70d293979b40c55b1a19bfe9da2.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/754df28c6876f1ad13f55cc4ed86680f.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bce0a7e5d4761007f507c835a0436b8.webp",980,1268]